The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt policies on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation.
Racetrack veterinarians told the Ohio State Racing Commission April 28 they support uniform medication policies, but because their top priority is the welfare of the racehorse, the state's rules should remain in place.
The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses.
The executive committee of the Racing Medication and Testing Consortium (RMTC) has approved a uniform testing threshold of 110 parts per billion (ppb) in blood for the naturally occurring amino acid gamma-aminobutyric acid.
The Racing Medication and Testing Consortium hopes to have a recommended testing threshold level by late April for a naturally occurring amino acid that has a calming effect on racehorses.
The board of directors of the Racing Medication and Testing Consortium (RMTC) today announced that a uniform threshold for cobalt regulation in the U.S. was approved at its March 24 meeting at Gulfstream Park.
Setting the testing threshold for cobalt chloride has become the challenge of racing regulators. North American racing has been well behind in its application of a satisfactory testing threshold applied across all states.
The head of the Association of Racing Commissioners International has reiterated the organization's intention to push for a uniform approach for regulation of cobalt.
As the Ohio State Racing Commission begins a comprehensive review of its medication rules and examines the National Uniform Medication Program, it has a hired a longtime veterinarian to consult on policies and procedures.
The Racing Medication and Testing Consortium may be close to recommending policy on the endogenous element cobalt, which when administered in high doses is believed to enhance production of red blood cells.
In 2014, U.S. horse racing appeared on pace to register its fewest positive drug tests for anabolic steroids since the industry moved to outlaw the drugs from racing in 2008-09. But recent events in Maryland changed that.
The sale company will follow the uniform medication model rules adopted for racing by the Association of Racing Commissioners International. Medication rule changes will begin in March.
Though the Association of Racing Commissioners International remains a member of the Racing Medication and Testing Consortium, it intends to take the lead role in gathering the information needed to set medication policies.
As part of an examination of its equine medication rules, the Ohio State Racing Commission in February will begin hearing from various industry organizations involved in an effort to adopt uniform policies for all states.
The industry's Racing Medication and Testing Consortium plans to reorganize its own Scientific Advisory Committee but does not plan to merge with the Association of Racing Commissioners International.
The Association of Racing Commissioners International board has selected five initial members for its new Drug Testing Standards and Practices Committee.
The Association of Racing Commissioners International has asked that the industry's Racing Medication and Testing Consortium be merged into a new RCI scientific advisory board.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
The Breeders' Cup World Championships will be held for the first time under reforms included in the National Uniform Medication Program.
The Racing Medication and Testing Consortium believes the majority of racing jurisdictions will have a substantial portion of the National Uniform Medication Program in place by year's end.
- By Tom LaMarra
Research commissioned by The Jockey Club shows that, though the Thoroughbred industry has made progress in the area of uniform medication and testing standards, a state-by-state approach is at best problematic.
- By Tom LaMarra
United States Trotting Association-funded research into cobalt has resulted in a regulatory testing threshold of 70 parts per billion, the organization said Sept. 30.
The Arkansas Racing Commission approved the entire program Sept. 11. Once implemented, Arkansas will become the sixth state to fully administer the Racing Medication and Testing Consortium's National Uniform Medication rules.
In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
No getting around the need for a national medication policy. read blog
The Jockey Club Aug. 10 acknowledged progress on the effort to adopt uniform medication and drug-testing rules on a state-by-state basis, but also said it will advocate on the federal level for assistance.
Following a presentation by RMTC executive director Dionne Benson, the Thoroughbred Owners and Breeders Association has issued a statement pledging support of the uniform medication program.
Advocates for change in horse racing didn't find much reason for optimism in the National Thoroughbred Racing Association's legislative update held in Saratoga Springs Aug. 7.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Racing Medication and Testing Consortium executive director Dionne Benson discussed the implications of a British steroid ban on U.S. horses Aug. 6 during TOBA's annual members meeting.
Before making a formal recommendation of a regulatory testing limit on cobalt, North American racing regulators have decided to consider the results of two scientific research studies.
The West Virginia Racing Commission Aug. 1 hired Truesdail Laboratories in California to handle its equine drug testing and will ask the lab to test about 40 "cloudy samples" from a three-week period in July.
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
Churchill Downs Inc. on July 31 became the 24th racetrack entity in the United States to commit to making a contribution to the Racing Medication and Testing Consortium.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
Kentucky Thoroughbred Association/Kentucky Thoroughbred Owners and Breeders executive director David Switzer announced June 10 that he will retire from the organization Aug. 1 after 21 years at the helm.
Saying the current withdrawal time on the books for flunixin (Banamine) could leave New York horsemen and veterinarians vulnerable to positive tests, the NYTHA is recommending extending the time by an additional eight hours.
The Indiana Horse Racing Commission April 30 adopted the Controlled Therapeutic Medication Schedule and multiple medication violation penalty system, but a watchdog organization said it's premature to call it uniformity.
The Horseracing Testing Laboratory Committee of the Racing Medication and Testing Consortium has approved full accreditation of three laboratories, it announced April 30.
The National HBPA said April 11 it supports changes made by the Association of Racing Commissioners International in regard to uniform medication regulations.
Florida and Arkansas illustrate the challenges in obtaining uniformity. read blog
Racing jurisdictions have made progress on equine medication reform but states and their regulatory agencies must commit to move quickly and in unison, said Alex Waldrop, president of the NTRA and chairman of the RMTC.
Alan Foreman responds to criticism that little progress has been made on medication reform.
Racing industry organizations have greatly stepped up their call for swift adoption of national model rules on medication and drug testing in the wake of probes into allegations of mistreatment and over-medication of horses.
The Racing Medication and Testing Consortium board of directors took several actions March 17 intended to further the process toward the nationwide adoption of uniform medication rules, penalties, and testing.
New York racing regulators raised the prospects of imposing new transparency standards on stewards, including possibly publicly releasing videos that are used by officials in decisions affecting the outcome of a race.
Gulfstream Park will become the first racetrack to use the graded stakes out-of-competition testing grant fund, beginning with the March 29 Besilu Stables Florida Derby (gr. I), it was announced March 11.
When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
A booklet put together by several individuals at the forefront of equine medication reform has been prepared for Maryland, which will enact the Mid-Atlantic Uniform Medication and Drug-Testing Program Jan. 1, 2014.
Most Popular Stories
- Aldous Snow Repeats in Singspiel Stakes
- Strut the Course Edges Favorite at Woodbine
- Front-Runner Dogwood Trail Blossoms in Azalea
- Nutan Easy Winner of German Derby
- Favorites Dominate on Louisiana Legends Night
- Jockey Gonzalez Posts Career Victory 3,000
- Lady Eli Sparkles in Belmont Oaks
- American Pharoah to Haskell
- Gimme Da Lute Holds On in Los Alamitos Derby
- Effinex Outlasts Tonalist at Wire in Suburban